Company enters 2026 with reduced leverage, extended debt maturity and added liquidity
Pursues top-line stabilization and margin expansion with strategic brand repositioning to Beyond The Plant Protein Company™
Fourth Quarter 2025 Financial Highlights1
- Net revenues were
$61.6 million , a decrease of 19.7% year-over-year. - Gross profit was
$1.4 million , or gross margin of 2.3%, compared to gross profit of$10.0 million , or gross margin of 13.1%, in the year-ago period.- Gross profit and gross margin included
$2.4 million in non-cash charges arising from incremental provision for excess and obsolete inventory as a result of SKU rationalization and the decision to discontinue certain product lines and$1.5 million in expenses related to the cessation of the Company’s operational activities inChina .
- Gross profit and gross margin included
- Loss from operations was
$132.7 million , or operating margin of -215.5%, compared to loss from operations of$37.8 million , or operating margin of -49.3%, in the year-ago period.- Loss from operations included
$48.1 million in non-cash charges related to the loss from write-down of assets held for sale. - Loss from operations also included the following charges recorded in operating expenses: a
$38.9 million non-cash litigation-related accrual;$13.3 million in incremental share-based compensation expense related to the Company’s convertible debt exchange;$0.8 million in certain non-routine SG&A expenses;$0.4 million in costs related to a partial lease termination of a portion of the Company’s campus headquarters building inEl Segundo, California (the “Campus Headquarters”); and$0.3 million in incremental legal and other fees and expenses associated with arbitration proceedings related to a previously-disclosed contractual dispute with a former co-manufacturer.
- Loss from operations included
- Net income was
$409.9 million , compared to net loss of$(44.9) million in the year-ago period. Net income per share available to common stockholders-basic was$0.84 , compared to net loss per share available to common stockholders-basic of$(0.65) in the year-ago period. Net loss per share available to common stockholders-diluted was$(0.29) , compared to net loss per share available to common stockholders-diluted of$(0.65) in the year-ago period- Net income included a
$548.7 million non-cash gain on debt restructuring.
- Net income included a
- Adjusted EBITDA was a loss of
$69.0 million , or -112.1% of net revenues, compared to an Adjusted EBITDA loss of$26.0 million , or -33.9% of net revenues, in the year-ago period.
Full Year 2025 Financial Highlights1
- Net revenues were
$275.5 million , a decrease of 15.6% year-over-year. - Gross profit was
$7.6 million , or gross margin of 2.8%, compared to gross profit of$41.7 million , or gross margin of 12.8%, in the year-ago period.- Gross profit and gross margin included
$6.7 million in non-cash charges arising from specific initiatives that increased inventory provision and$5.8 million in expenses related to the cessation of the Company’s operational activities inChina .
- Gross profit and gross margin included
- Loss from operations was
$332.7 million , or operating margin of -120.8%, compared to loss from operations of$156.1 million , or operating margin of -47.8%, in the year-ago period.- Loss from operations included
$51.3 million in loss from impairment of long-lived assets and$48.1 million in non-cash charges related to the loss on write-down of assets held for sale. - Loss from operations also included the following charges recorded in operating expenses: a
$38.9 million non-cash litigation-related accrual;$13.3 million in incremental share-based compensation expenses related to the Company’s convertible debt exchange;$8.1 million in incremental legal and other fees and expenses associated with arbitration proceedings related to a previously-disclosed contractual dispute with a former co-manufacturer;$2.2 million in certain non-routine SG&A expenses;$1.4 million in costs related to a partial lease termination of a portion of the Company’s Campus Headquarters; and$1.3 million in expenses related to the suspension and cessation of the Company’s operational activities inChina .
- Loss from operations included
- Net income was
$219.9 million , compared to net loss of$(160.3) million in the year-ago period. Net income per share available to common stockholders-basic in 2025 was$1.15 , compared to net loss per share available to common stockholders-basic of$(2.43) in the year-ago period. Net loss per share available to common stockholders-diluted in 2025 was$(1.86) , compared to net loss per share available to common stockholders-diluted of$(2.43) in the year-ago period.- Net income included a
$548.7 million non-cash gain on debt restructuring.
- Net income included a
- Adjusted EBITDA was a loss of
$178.4 million , or -64.8% of net revenues, compared to an Adjusted EBITDA loss of$101.7 million , or -31.1% of net revenues, in the year-ago period.
_____________________
1 This release includes references to non-GAAP financial measures. Refer to “Non-GAAP Financial Measures” later in this release for the definitions of the non-GAAP financial measures presented and a reconciliation of these measures to their closest comparable GAAP measures.
Beyond Meat President and CEO
Brown continued, “We enter 2026 with reduced leverage and extended debt maturity, and having added liquidity to our balance sheet. We intend to build on these improvements through the continued pursuit of top-line stabilization and margin expansion. Furthermore, we are strategically repositioning our brand to Beyond The Plant Protein Company™, allowing us to enter into adjacent categories where we believe our brand, technology and commitment to clean plant-based nutrition can deliver significant value to consumers.”
Fourth Quarter 2025
Net revenues decreased 19.7% to
International retail channel net revenues decreased 32.5% to
International foodservice channel net revenues decreased 31.8% to
Net revenues by channel (unaudited):
The following tables present the Company’s net revenues by channel for the periods presented:
| Three Months Ended | Change | ||||||||||||
| (in thousands) | 2025 | 2024 | Amount | % | |||||||||
| Retail | $ | 31,672 | $ | 33,886 | $ | (2,214 | ) | (6.5 | )% | ||||
| Foodservice | 7,971 | 10,452 | (2,481 | ) | (23.7 | )% | |||||||
| 39,643 | 44,338 | (4,695 | ) | (10.6 | )% | ||||||||
| International: | |||||||||||||
| Retail | $ | 8,807 | $ | 13,055 | $ | (4,248 | ) | (32.5 | )% | ||||
| Foodservice | 13,139 | 19,265 | (6,126 | ) | (31.8 | )% | |||||||
| International net revenues | 21,946 | 32,320 | (10,374 | ) | (32.1 | )% | |||||||
| Net revenues | $ | 61,589 | $ | 76,658 | $ | (15,069 | ) | (19.7 | )% | ||||
| Year Ended | Change | ||||||||||||
| (in thousands) | 2025 | 2024 | Amount | % | |||||||||
| Retail | $ | 124,478 | $ | 150,812 | $ | (26,334 | ) | (17.5 | )% | ||||
| Foodservice | 38,963 | 47,584 | (8,621 | ) | (18.1 | )% | |||||||
| 163,441 | 198,396 | (34,955 | ) | (17.6 | )% | ||||||||
| International: | |||||||||||||
| Retail | $ | 53,166 | $ | 59,783 | $ | (6,617 | ) | (11.1 | )% | ||||
| Foodservice | 58,889 | 68,273 | (9,384 | ) | (13.7 | )% | |||||||
| International net revenues | 112,055 | 128,056 | (16,001 | ) | (12.5 | )% | |||||||
| Net revenues | $ | 275,496 | $ | 326,452 | $ | (50,956 | ) | (15.6 | )% | ||||
Volume of products sold by channel (unaudited):
The following table presents consolidated volume of the Company’s products sold in pounds for the periods presented:
| Three Months Ended | Change | Year Ended | Change | |||||||||||||||||
| (in thousands) | 2025 | 2024 | Amount | % | 2025 | 2024 | Amount | % | ||||||||||||
| Retail | 6,166 | 6,596 | (430 | ) | (6.5 | )% | 23,920 | 28,892 | (4,972 | ) | (17.2 | )% | ||||||||
| Foodservice | 1,371 | 1,831 | (460 | ) | (25.1 | )% | 6,413 | 7,892 | (1,479 | ) | (18.7 | )% | ||||||||
| International: | ||||||||||||||||||||
| Retail | 1,811 | 2,725 | (914 | ) | (33.5 | )% | 11,013 | 13,141 | (2,128 | ) | (16.2 | )% | ||||||||
| Foodservice | 3,884 | 5,890 | (2,006 | ) | (34.1 | )% | 17,571 | 20,109 | (2,538 | ) | (12.6 | )% | ||||||||
| Volume of products sold | 13,232 | 17,042 | (3,810 | ) | (22.4 | )% | 58,917 | 70,034 | (11,117 | ) | (15.9 | )% | ||||||||
Gross profit in the fourth quarter of 2025 was
Operating expenses were
Loss from operations in the fourth quarter of 2025 was
The following table summarizes certain charges recorded in the Company’s consolidated statement of operations for the fourth quarter of 2025 (unaudited):
| (in thousands) | 2025 | |
| Charges recorded in cost of goods sold: | ||
| Incremental obsolescence provision related to SKU rationalization | ||
| Expenses related to cessation of operational activities in | ||
| Total charges recorded in cost of goods sold | ||
| Charges recorded in operating expenses: | ||
| Loss on write-down of assets held for sale | ||
| Litigation-related accrual | ||
| Incremental non-cash share-based compensation expense | ||
| Certain non-routine SG&A expenses | ||
| Costs related to partial lease termination | ||
| Incremental legal expenses related to contractual dispute with former co-manufacturer | ||
| Expenses related to cessation of operational activities in | ||
| Total charges recorded in operating expenses | ||
| Total | $105,705 | |
Total other income, net, was
Net income was
Adjusted EBITDA was a loss of
Balance Sheet and Cash Flow Highlights
The Company’s cash and cash equivalents balance, including restricted cash, was
Correction of Previously Issued Interim Condensed Consolidated Financial Statements
During its fourth quarter and full year 2025 financial close procedures, the Company determined that, in addition to a previously identified material weakness related to the accounting for non-routine and complex transactions, an additional material weakness in internal control over financial reporting existed as of
The Company has determined that the errors identified were immaterial to the previously issued interim condensed consolidated financial statements for the first three quarters of 2025 and that the errors will be corrected prospectively when the Company files its quarterly reports in fiscal 2026. For a full discussion of these matters, investors can refer to Item 9A—Controls and Procedures, and Item 9B—Other Information, in the Company’s 2025 Annual Report on Form 10-K, to be filed with the
A summary of the revisions to the impacted financial statement line items in the Company’s previously issued interim condensed consolidated financial Statements for 2025 is shown on the attached schedule at the end of this release.
Annual Report on Form 10-K
The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended
2026 Outlook
The Company continues to experience an elevated level of uncertainty within its operating environment, which has, and management believes will continue to have, unforeseen impacts on the Company’s actual realized results. In light of this uncertainty, the Company is limiting its outlook to the following:
- In the first quarter of 2026, net revenues are expected to be approximately
$57 million to$59 million .
Conference Call and Webcast
The Company will host a conference call to discuss these results at
About Beyond Meat
Forward-Looking Statements
Certain statements in this release constitute “forward-looking statements" within the meaning of the federal securities laws, including statements related to the Company’s expectations with respect to its first quarter 2026 outlook.
Forward-looking statements are based on management's current opinions, expectations, beliefs, plans, objectives, assumptions and projections regarding financial performance, prospects, future events and future results, including ongoing uncertainty related to macroeconomic issues, including high inflation and interest rates, prolonged, weakening demand in the plant-based meat category, ongoing concerns about the likelihood of a recession and increased competition, and the Company’s ability to regain timely filer status, among other matters, and involve known and unknown risks that are difficult to predict. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “outlook,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. These forward-looking statements are only predictions, not historical fact, and involve certain risks and uncertainties, as well as assumptions. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which or whether, such performance or results will be achieved. Actual results, levels of activity, performance, achievements and events could differ materially from those stated, anticipated or implied by such forward-looking statements. While Beyond Meat believes that its assumptions are reasonable, it is very difficult to predict the impact of known factors and, of course, it is impossible to anticipate all factors that could affect actual results. There are many risks and uncertainties that could cause actual results to differ materially from forward-looking statements made herein including, but not limited to: a further decrease in demand, and the underlying factors negatively impacting demand, in the plant-based meat category, including the exacerbation of weakness in the category by the macroeconomic trends discussed in this release; the success of our marketing initiatives and the ability to maintain and grow our brand awareness, maintain, protect and enhance our brand, or rebrand altogether, attract and retain new customers and maintain and grow our market share, particularly while we are seeking to reduce our operating expenses; changes in the retail landscape, including our ability to maintain and expand our distribution footprint, the timing, success and level of trade and promotion discounts, our ability to maintain and grow market share and increase household penetration, repeat purchases, buying rates (amount spent per buyer) and purchase frequency, our ability to maintain and increase sales velocity of our products, and the timing and success of our efforts to expand distribution channels, such as our direct-to-consumer (DTC) channel, and planned new products or recently launched products; our ability to successfully innovate and commercialize new plant-based protein products, including in adjacent categories outside of our core, meat analogue offerings, and consumer acceptance of such new products; the sufficiency of our cash and cash equivalents to meet our liquidity needs, including estimates of our expenses, future revenues, capital expenditures and capital requirements; our ability to obtain additional equity and/or debt financing, the terms of any such financing, and our ability to continue to bolster our balance sheet; risks associated with our indebtedness, leverage and liquidity relating to our significant debt, including our ability to repay or refinance and otherwise satisfy our obligations under each of the Loan and Security Agreement (as defined below), our 0% Convertible Senior Notes due 2027 (the “2027 Notes”) that remain outstanding and our 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 (the “2030 Notes” and, together with the 2027 Notes, the “Notes”) issued in the exchange offer related to the 2027 Notes, which was completed on
Non-GAAP Financial Measures
The Company refers to certain financial measures that are not recognized under
Availability of Information on Beyond Meat’s Website and Social Media Channels
Investors and others should note that Beyond Meat routinely announces material information to investors and the marketplace using
Contacts
Media:
shira.zackai@beyondmeat.com
Investors:
beyondmeat@icrinc.com
Consolidated Statements of Operations
(In thousands, except share and per share data)
(unaudited)
| Three Months Ended | Year Ended | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
| Net revenues | $ | 61,589 | $ | 76,658 | $ | 275,496 | $ | 326,452 | ||||||||
| Cost of goods sold | 60,165 | 66,652 | 267,850 | 284,753 | ||||||||||||
| Gross profit (loss) | 1,424 | 10,006 | 7,646 | 41,699 | ||||||||||||
| Research and development expenses | 5,049 | 6,671 | 23,235 | 28,149 | ||||||||||||
| Selling, general and administrative expenses | 81,017 | 41,145 | 217,757 | 169,674 | ||||||||||||
| Loss on write-down of assets held for sale | 48,101 | — | 48,101 | — | ||||||||||||
| Loss from impairment of long-lived assets | — | — | 51,288 | — | ||||||||||||
| Total operating expenses | 134,167 | 47,816 | 340,381 | 197,823 | ||||||||||||
| Loss from operations | (132,743 | ) | (37,810 | ) | (332,735 | ) | (156,124 | ) | ||||||||
| Other income (expense), net: | ||||||||||||||||
| Interest expense | (6,584 | ) | (1,025 | ) | (14,028 | ) | (4,097 | ) | ||||||||
| Remeasurement of warrant liability | 10,303 | — | 15,077 | — | ||||||||||||
| Remeasurement of derivative liability | (12,288 | ) | — | (12,288 | ) | — | ||||||||||
| Gain on debt restructuring | 548,651 | — | 548,651 | — | ||||||||||||
| Other, net | 2,512 | (6,015 | ) | 15,311 | (10 | ) | ||||||||||
| Total other income (expense), net | 542,594 | (7,040 | ) | 552,723 | (4,107 | ) | ||||||||||
| Income (loss) before taxes | 409,851 | (44,850 | ) | 219,988 | (160,231 | ) | ||||||||||
| Income tax benefit | — | — | — | (26 | ) | |||||||||||
| Equity in losses of unconsolidated joint venture | 1 | 12 | 78 | 73 | ||||||||||||
| Net income (loss) | $ | 409,850 | $ | (44,862 | ) | $ | 219,910 | $ | (160,278 | ) | ||||||
| Less: Earnings allocated to participating securities | (91,921 | ) | — | (41,178 | ) | — | ||||||||||
| Net income (loss) available to common stockholders—basic | $ | 317,929 | $ | (44,862 | ) | $ | 178,732 | $ | (160,278 | ) | ||||||
| Net income (loss) per share available to common stockholders—basic | $ | 0.84 | $ | (0.65 | ) | $ | 1.15 | $ | (2.43 | ) | ||||||
| Weighted average common shares outstanding—basic | 379,248,614 | 69,235,143 | 155,266,711 | 66,004,815 | ||||||||||||
| Net income (loss) per share available to common stockholders—diluted | $ | (0.29 | ) | $ | (0.65 | ) | $ | (1.86 | ) | $ | (2.43 | ) | ||||
| Weighted average common shares outstanding—diluted | 477,779,608 | 69,235,143 | 181,324,268 | 66,004,815 | ||||||||||||
Reconciliation of Net Income (Loss) Per Share Available to Common Stockholders—Basic to Net Loss Per Share Available to Common Stockholders—Diluted (In thousands, except share and per share data) (unaudited) | ||||||||||||||||
| (in thousands, except share and per share data) | Three Months Ended | Year Ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Numerator(1): | ||||||||||||||||
| Basic | ||||||||||||||||
| Net income (loss) | $ | 409,850 | $ | (44,862 | ) | $ | 219,910 | $ | (160,278 | ) | ||||||
| Less: Earnings allocated to participating securities | (91,921 | ) | — | (41,178 | ) | — | ||||||||||
| Net income (loss) available to common stockholders—basic | $ | 317,929 | $ | (44,862 | ) | $ | 178,732 | $ | (160,278 | ) | ||||||
| Diluted | ||||||||||||||||
| Net income (loss) available to common stockholders—basic | $ | 317,929 | $ | (44,862 | ) | $ | 178,732 | $ | (160,278 | ) | ||||||
| Net income available to 2030 Note holders | 82,600 | — | 29,521 | — | ||||||||||||
| Net income available to warrant holders | 8,013 | — | 4,178 | — | ||||||||||||
| Add: Interest expense on 2030 Notes, if converted(2) | 1,119 | — | 1,119 | — | ||||||||||||
| Less: Gain on debt restructuring | (548,651 | ) | — | (548,651 | ) | — | ||||||||||
| Less: Gain on remeasurement of warrant liability | (10,303 | ) | — | (15,077 | ) | — | ||||||||||
| Add: Loss on remeasurement of derivative liability | 12,288 | — | 12,288 | — | ||||||||||||
| Net loss available to common stockholders—diluted | $ | (137,005 | ) | $ | (44,862 | ) | $ | (337,890 | ) | $ | (160,278 | ) | ||||
| Denominator: | ||||||||||||||||
| Basic | ||||||||||||||||
| Weighted average common shares outstanding—basic | 379,248,614 | 69,235,143 | 155,266,711 | 66,004,815 | ||||||||||||
| Net income (loss) per share available to common stockholders—basic | $ | 0.84 | $ | (0.65 | ) | $ | 1.15 | $ | (2.43 | ) | ||||||
| Diluted | ||||||||||||||||
| Weighted average common shares outstanding—basic | 379,248,614 | 69,235,143 | 155,266,711 | 66,004,815 | ||||||||||||
| Dilutive effect of 2030 Notes, if converted | 98,530,994 | — | 25,645,054 | — | ||||||||||||
| Dilutive effect of Warrants(3) | — | — | 412,503 | — | ||||||||||||
| Weighted average common shares outstanding—diluted | 477,779,608 | 69,235,143 | 181,324,268 | 66,004,815 | ||||||||||||
| Net loss per share available to common stockholders—diluted | $ | (0.29 | ) | $ | (0.65 | ) | $ | (1.86 | ) | $ | (2.43 | ) | ||||
____________
(1) Under the if-converted method, net income (loss) is adjusted to reflect the assumption that the convertible notes were converted at the beginning of the period or date of issuance, if issued during the period.
(2) In 2025, included amortization of 2030 Notes derivative liability to interest expense.
(3) Dilutive effect of Warrants using the treasury stock method.
| Consolidated Balance Sheets | |||||||
| (In thousands, except share and per share data) | |||||||
| (unaudited) | |||||||
| 2025 | 2024 | ||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 203,890 | $ | 131,913 | |||
| Restricted cash, current | 4,350 | 1,041 | |||||
| Accounts receivable, net | 26,060 | 26,862 | |||||
| Inventory | 84,032 | 113,444 | |||||
| Prepaid expenses and other current assets | 13,758 | 11,332 | |||||
| Assets held for sale | 10,280 | 1,864 | |||||
| Total current assets | 342,370 | 286,456 | |||||
| Restricted cash, non-current | 9,291 | 12,600 | |||||
| Property, plant, and equipment, net | 213,262 | 184,887 | |||||
| Operating lease right-of-use assets | 5,661 | 123,975 | |||||
| Prepaid lease costs, non-current | 43,526 | 68,005 | |||||
| Other non-current assets, net | — | 622 | |||||
| Investment in unconsolidated joint venture | 1,523 | 1,601 | |||||
| Total assets | $ | 615,633 | $ | 678,146 | |||
| Liabilities and stockholders’ deficit: | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 20,525 | $ | 37,571 | |||
| Current portion of operating lease liabilities | 2,132 | 4,125 | |||||
| Accrued expenses and other current liabilities | 8,975 | 11,656 | |||||
| Accrued litigation expenses | 38,900 | — | |||||
| Accrued litigation settlement | — | 7,250 | |||||
| Short-term finance lease liabilities | 4,385 | 851 | |||||
| Total current liabilities | $ | 74,917 | $ | 61,453 | |||
| Long-term liabilities: | |||||||
| 2027 Notes, net | $ | 29,459 | $ | 1,141,476 | |||
| 2030 Notes, net | 308,404 | — | |||||
| Delayed draw term loans, net | 77,877 | — | |||||
| Delayed draw term loan warrants at fair value | 5,066 | — | |||||
| Operating lease liabilities, net of current portion | 4,059 | 73,613 | |||||
| Finance lease liabilities, long-term | 76,590 | 2,812 | |||||
| 2030 Embedded Derivative Liability, at fair value | 39,152 | — | |||||
| Other long term liabilities | 220 | — | |||||
| Total long-term liabilities | $ | 540,827 | $ | 1,217,901 | |||
| Commitments and contingencies | |||||||
| Stockholders’ deficit: | |||||||
| Preferred stock, par value | $ | — | $ | — | |||
| Common stock, par value | 45 | 8 | |||||
| Additional paid-in capital | 1,029,308 | 644,004 | |||||
| Accumulated deficit | (1,021,621 | ) | (1,241,531 | ) | |||
| Accumulated other comprehensive loss | (7,843 | ) | (3,689 | ) | |||
| Total stockholders’ deficit | $ | (111 | ) | $ | (601,208 | ) | |
| Total liabilities and stockholders’ deficit | $ | 615,633 | $ | 678,146 | |||
| Consolidated Statements of Cash Flows | ||||||||
| (In thousands) | ||||||||
| (unaudited) | ||||||||
| Year Ended | ||||||||
| 2025 | 2024 | |||||||
| Cash flows from operating activities: | ||||||||
| Net income (loss) | $ | 219,910 | $ | (160,278 | ) | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
| Loss from impairment of long-lived assets | 51,288 | — | ||||||
| Depreciation and amortization | 32,773 | 23,121 | ||||||
| Non-cash lease expense | 3,960 | 8,279 | ||||||
| Share-based compensation expense | 30,990 | 23,923 | ||||||
| Provision for credit losses | 1 | 221 | ||||||
| Amortization of debt issuance costs | 4,987 | 3,934 | ||||||
| Loss on write-down of assets held for sale | 48,449 | 809 | ||||||
| Equity in losses of unconsolidated joint venture | 78 | 73 | ||||||
| Change in common stock warrant liability | (15,077 | ) | — | |||||
| Change in derivative liability | 12,288 | — | ||||||
| Write-down of note receivable | 136 | — | ||||||
| Gain on debt restructuring | (557,909 | ) | — | |||||
| Unrealized (gains) losses on foreign currency transactions | (12,066 | ) | 5,113 | |||||
| Paid-in-kind interest | 4,569 | — | ||||||
| Net change in operating assets and liabilities: | ||||||||
| Accounts receivable | 1,650 | 4,193 | ||||||
| Inventories | 31,654 | 15,576 | ||||||
| Prepaid expenses and other current assets | (4,924 | ) | 2,013 | |||||
| Accounts payable | (15,204 | ) | (20,564 | ) | ||||
| Accrued expenses and other current liabilities | 28,767 | 4,511 | ||||||
| Prepaid lease costs, non-current | (8,268 | ) | (6,502 | ) | ||||
| Operating lease liabilities | (3,203 | ) | (3,235 | ) | ||||
| Long-term liabilities | 220 | — | ||||||
| Net cash used in operating activities | $ | (144,931 | ) | $ | (98,813 | ) | ||
| Cash flows from investing activities: | ||||||||
| Purchases of property, plant and equipment | $ | (12,308 | ) | $ | (11,015 | ) | ||
| Proceeds from sale of fixed assets | 1,942 | 4,348 | ||||||
| Proceeds from note receivable on assets previously held for sale | 84 | — | ||||||
| Payments for investment in joint venture | — | — | ||||||
| Proceeds from security deposits | 32 | 435 | ||||||
| Net cash used in investing activities | $ | (10,250 | ) | $ | (6,232 | ) | ||
| Cash flows from financing activities: | ||||||||
| Proceeds from issuance of common stock pursuant to the ATM Program, net of issuance costs | $ | 148,699 | $ | 46,725 | ||||
| Proceeds from delayed draw term loans | 100,000 | — | ||||||
| Payment of debt issuance costs | (15,604 | ) | — | |||||
| Payment of equity issuance costs | (6,535 | ) | — | |||||
| Principal payments under finance lease obligations | (2,732 | ) | (1,177 | ) | ||||
| Proceeds from exercise of stock options | 6 | 924 | ||||||
| Payments of minimum withholding taxes on net share settlement of equity awards | (424 | ) | (695 | ) | ||||
| Net cash provided by (used in) financing activities | $ | 223,410 | $ | 45,777 | ||||
| Net decrease in cash, cash equivalents and restricted cash | 68,229 | (59,268 | ) | |||||
| Cash, cash equivalents and restricted cash at the beginning of the period | 145,554 | 205,935 | ||||||
| Effect of foreign currency exchange rate changes on cash | 3,748 | (1,113 | ) | |||||
| Cash, cash equivalents and restricted cash at the end of the period | $ | 217,531 | $ | 145,554 | ||||
| Supplemental disclosures of cash flow information: | ||||||||
| Cash paid (received) during the period for: | ||||||||
| Interest | $ | — | $ | — | ||||
| Taxes | $ | 2 | $ | 6 | ||||
Non-GAAP Financial Measures
Beyond Meat uses the non-GAAP financial measures set forth below in assessing its operating performance and in its financial communications. Management believes these non-GAAP financial measures provide useful additional information to investors about current trends in our operations and are useful for period-over-period comparisons of operations. In addition, management uses these non-GAAP financial measures to assess operating performance and for business planning purposes. Management also believes these measures are widely used by investors, securities analysts, rating agencies and other parties in evaluating companies in our industry as a measure of our operational performance. These non-GAAP financial measures should not be considered in isolation or as substitutes for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be computed in the same manner as similarly titled measures used by other companies.
“Adjusted loss from operations” is defined as loss from operations adjusted to exclude, when applicable, costs attributable to special items, which are those items deemed not to be reflective of the Company’s ongoing normal business activities.
“Adjusted operating margin” is defined as Adjusted loss from operations divided by net revenues.
We consider Adjusted loss from operations and Adjusted operating margin to be useful indicators of operating performance because excluding special items allows for period-over-period comparisons of our ongoing operations.
“Adjusted EBITDA” is defined as net income (loss) adjusted to exclude, when applicable, income tax (benefit) expense, interest expense, depreciation and amortization expense, restructuring expenses, share-based compensation expense, non-cash charges related to the cessation of our operational activities in
“Adjusted EBITDA as a % of net revenues” is defined as Adjusted EBITDA divided by net revenues.
There are a number of limitations related to the use of Adjusted EBITDA and Adjusted EBITDA as a % of net revenues rather than their most directly comparable GAAP measures. Some of these limitations are:
- Adjusted EBITDA excludes depreciation and amortization expense and, although these are non-cash expenses, the assets being depreciated may have to be replaced in the future increasing our cash requirements;
- Adjusted EBITDA does not reflect interest expense, or the cash required to service our debt, which reduces cash available to us;
- Adjusted EBITDA does not reflect income tax payments that reduce cash available to us;
- Adjusted EBITDA does not reflect restructuring expenses that reduce cash available to us;
- Adjusted EBITDA does not reflect share-based compensation expense and therefore does not include all of our compensation costs;
- Adjusted EBITDA does not reflect non-cash charges related to the cessation of our operational activities in
China ; - Adjusted EBITDA does not reflect certain cash costs related to a partial lease termination of a portion of the Campus Headquarters, which reduces cash available to us;
- Adjusted EBITDA does not reflect non-cash loss from impairment of long-lived assets and therefore does not include all of our operating expenses;
- Adjusted EBITDA does not reflect litigation-related accruals, which may, depending on the outcome of the underlying litigation, reduce cash available to us;
- Adjusted EBITDA does not reflect accrued litigation settlement costs which reduce cash available to us;
- Adjusted EBITDA does not reflect non-cash impact of the remeasurement of warrant liability;
- Adjusted EBITDA does not reflect the non-cash impact of the remeasurement of derivative liability;
- Adjusted EBITDA does not include gain on debt restructuring, the income from which may in certain circumstances be taxable to us and reduce the cash available to us;
- Adjusted EBITDA does not reflect Other, net, including interest income and foreign currency transaction gains and losses, that may increase or decrease cash available to us; and
- other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure.
The following tables present the reconciliation of Adjusted loss from operations and Adjusted operating margin to their most comparable GAAP measures, loss from operations and operating margin, each as reported (unaudited):
| Adjusted loss from operations: | |||||||||||||||
| Three Months Ended | Year Ended | ||||||||||||||
| (in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||
| Loss from operations, as reported | $ | (132,743 | ) | $ | (37,810 | ) | $ | (332,735 | ) | $ | (156,124 | ) | |||
| Loss from impairment of long-lived assets | — | — | 51,288 | — | |||||||||||
| Non-cash charges related to the cessation of operational activities in | 1,527 | — | 6,490 | — | |||||||||||
| Costs related to partial lease termination | 386 | — | 1,441 | — | |||||||||||
| Litigation-related accrual | 38,900 | — | 38,900 | — | |||||||||||
| Accrued litigation settlement costs | — | — | — | 7,500 | |||||||||||
| Adjusted loss from operations | $ | (91,930 | ) | $ | (37,810 | ) | $ | (234,616 | ) | $ | (148,624 | ) | |||
| Loss from operations as a % of net revenues | (215.5 | )% | (49.3 | )% | (120.8 | )% | (47.8 | )% | |||||||
| Adjusted operating margin | (149.3 | )% | (49.3 | )% | (85.2 | )% | (45.5 | )% | |||||||
The following table presents the reconciliation of Adjusted EBITDA to its most comparable GAAP measure, net income (loss), as reported (unaudited):
| Three Months Ended | Year Ended | |||||||||||||||
| (in thousands) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net income (loss), as reported | $ | 409,850 | $ | (44,862 | ) | $ | 219,910 | $ | (160,278 | ) | ||||||
| Income tax benefit | — | — | — | (26 | ) | |||||||||||
| Interest expense | 6,584 | 1,025 | 14,028 | 4,097 | ||||||||||||
| Depreciation and amortization expense(1) | 6,203 | 5,657 | 26,283 | 23,121 | ||||||||||||
| Share-based compensation expense | 3,799 | 6,170 | 17,723 | 23,923 | ||||||||||||
| Incremental share-based compensation expense(2) | 13,267 | — | 13,267 | — | ||||||||||||
| Non-cash charges related to the cessation of operational activities in | 1,527 | — | 6,490 | — | ||||||||||||
| Costs related to partial lease termination, net of amounts included in depreciation and amortization expense | — | — | 443 | — | ||||||||||||
| Loss from impairment of long-lived assets | — | — | 51,288 | — | ||||||||||||
| Litigation-related accrual | 38,900 | 38,900 | — | |||||||||||||
| Accrued litigation settlement costs | — | — | — | 7,500 | ||||||||||||
| Remeasurement of warrant liability | (10,303 | ) | — | (15,077 | ) | — | ||||||||||
| Remeasurement of derivative liability | 12,288 | — | 12,288 | — | ||||||||||||
| Gain on debt restructuring | (548,651 | ) | — | (548,651 | ) | — | ||||||||||
| Other, net(4)(5) | (2,512 | ) | 6,015 | (15,311 | ) | 10 | ||||||||||
| Adjusted EBITDA | $ | (69,048 | ) | $ | (25,995 | ) | $ | (178,419 | ) | $ | (101,653 | ) | ||||
| Net income (loss) as a % of net revenues | 665.5 | % | (58.5 | )% | 79.8 | % | (49.1 | )% | ||||||||
| Adjusted EBITDA as a % of net revenues | (112.1 | )% | (33.9 | )% | (64.8 | )% | (31.1 | )% | ||||||||
____________
| (1 | ) | Excludes |
| (2 | ) | Incremental share-based compensation from management incentive plan awards to certain key employees and acceleration of non-vested RSU awards granted to the Company’s non-employee directors in conjunction with the convertible debt exchange. |
| (3 | ) | Includes |
| (4 | ) | Includes |
| (5 | ) | Includes |
Schedule
Correction of Previously Issued Interim Condensed Consolidated Financial Statements
During the fourth quarter and full year 2025 financial close procedures, the Company identified errors in its previously issued interim condensed consolidated financial statements for the first three quarters of 2025 relating to (i) inventory valuation, (ii) debt issuance costs, and (iii) the previously disclosed impairment of long-lived assets, as described in further detail below. The Company has determined that the errors identified below were immaterial to the previously issued interim period condensed consolidated financial statements for the first three quarters of 2025 and that the errors will be corrected prospectively when the Company files its quarterly reports in fiscal 2026, and accordingly the "as corrected" amounts are presented in the tables below.
Inventory Valuation
Due to errors in the Company’s excess and obsolete inventory analysis, inventory was overstated and cost of goods sold were understated in each of the first three quarters of 2025.
Debt Issuance Costs
In connection with the Company’s 2025 balance sheet debt restructuring activities, namely, entry into the Delayed Draw Term Loan with Ahimsa (“DDTL”) and the debt exchange offer and restructuring which was completed in
Impairment of Long-Lived Assets (“Impairment”)
The Company recorded a loss from impairment of long-lived assets of
Due to the errors identified above related to inventory, prepaid expenses and other current assets, the carrying value of the entity-wide asset group as of
| Condensed Consolidated Balance Sheet (unaudited) | ||||||||||||||||
| (in thousands) | As of | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Inventory | $ | 100,068 | $ | (5,861 | ) | $ | — | $ | 94,207 | |||||||
| Prepaid expenses and other current assets | $ | 19,135 | $ | — | $ | (2,310 | ) | $ | 16,825 | |||||||
| Total current assets | $ | 257,272 | $ | (5,861 | ) | $ | (2,310 | ) | $ | 249,101 | ||||||
| Total assets | $ | 643,830 | $ | (5,861 | ) | $ | (2,310 | ) | $ | 635,659 | ||||||
| Accumulated deficit | $ | (1,294,447 | ) | $ | (5,861 | ) | $ | (2,310 | ) | $ | (1,302,618 | ) | ||||
| Total stockholders’ deficit | $ | (649,531 | ) | $ | (5,861 | ) | $ | (2,310 | ) | $ | (657,702 | ) | ||||
| Total liabilities and stockholders’ deficit | $ | 643,830 | $ | (5,861 | ) | $ | (2,310 | ) | $ | 635,659 | ||||||
| Condensed Consolidated Statement of Operations (unaudited) | ||||||||||||||||
| (in thousands) | Three Months Ended | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Cost of goods sold | $ | 69,796 | $ | 5,861 | $ | — | $ | 75,657 | ||||||||
| Gross loss | $ | (1,065 | ) | $ | (5,861 | ) | $ | — | $ | (6,926 | ) | |||||
| Selling, general and administrative expenses | $ | 47,672 | $ | — | $ | 2,310 | $ | 49,982 | ||||||||
| Total operating expenses | $ | 55,134 | $ | — | $ | 2,310 | $ | 57,444 | ||||||||
| Loss from operations | $ | (56,199 | ) | $ | (5,861 | ) | $ | (2,310 | ) | $ | (64,370 | ) | ||||
| Loss before taxes | $ | (52,905 | ) | $ | (5,861 | ) | $ | (2,310 | ) | $ | (61,076 | ) | ||||
| Net loss | $ | (52,916 | ) | $ | (5,861 | ) | $ | (2,310 | ) | $ | (61,087 | ) | ||||
| Net loss per share available to common stockholders—basic and diluted | $ | (0.69 | ) | $ | (0.08 | ) | $ | (0.03 | ) | $ | (0.80 | ) | ||||
| Condensed Consolidated Statement of Comprehensive Loss (unaudited) | ||||||||||||||||
| (in thousands) | Three Months Ended | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Net loss | $ | (52,916 | ) | $ | (5,861 | ) | $ | (2,310 | ) | $ | (61,087 | ) | ||||
| Comprehensive loss | $ | (53,956 | ) | $ | (5,861 | ) | $ | (2,310 | ) | $ | (62,127 | ) | ||||
| Condensed Consolidated Statement of Cash Flows (unaudited) | ||||||||||||||||
| (in thousands) | Three Months Ended | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Net loss | $ | (52,916 | ) | $ | (5,861 | ) | $ | (2,310 | ) | $ | (61,087 | ) | ||||
| Inventories | $ | 14,113 | $ | 5,861 | $ | — | $ | 19,974 | ||||||||
| Prepaid expenses and other current assets | $ | (4,425 | ) | $ | — | $ | 2,310 | $ | (2,115 | ) | ||||||
| Condensed Consolidated Balance Sheet (unaudited) | ||||||||||||||||
| (in thousands) | As of | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Inventory | $ | 110,868 | $ | (6,531 | ) | $ | — | $ | 104,337 | |||||||
| Prepaid expenses and other current assets | $ | 42,596 | $ | — | $ | (5,623 | ) | $ | 36,973 | |||||||
| Total current assets | $ | 297,135 | $ | (6,531 | ) | $ | (5,623 | ) | $ | 284,981 | ||||||
| Total assets | $ | 691,741 | $ | (6,531 | ) | $ | (5,623 | ) | $ | 679,587 | ||||||
| Delayed draw term loan, net | $ | 30,525 | $ | — | $ | (1,381 | ) | $ | 29,144 | |||||||
| Total long-term liabilities | $ | 1,278,577 | $ | — | $ | (1,381 | ) | $ | 1,277,196 | |||||||
| Accumulated deficit | $ | (1,323,689 | ) | $ | (6,531 | ) | $ | (4,242 | ) | $ | (1,334,462 | ) | ||||
| Total stockholders’ deficit | $ | (677,023 | ) | $ | (6,531 | ) | $ | (4,242 | ) | $ | (687,796 | ) | ||||
| Total liabilities and stockholders’ deficit | $ | 691,741 | $ | (6,531 | ) | $ | (5,623 | ) | $ | 679,587 | ||||||
| Condensed Consolidated Statement of Operations (unaudited) | ||||||||||||||||
| (in thousands) | Three Months Ended | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Cost of goods sold | $ | 66,367 | $ | 671 | $ | — | $ | 67,038 | ||||||||
| Gross profit | $ | 8,591 | $ | (671 | ) | $ | — | $ | 7,920 | |||||||
| Selling, general and administrative expenses | $ | 37,696 | $ | — | $ | 1,932 | $ | 39,628 | ||||||||
| Total operating expenses | $ | 43,503 | $ | — | $ | 1,932 | $ | 45,435 | ||||||||
| Loss from operations | $ | (34,912 | ) | $ | (671 | ) | $ | (1,932 | ) | $ | (37,515 | ) | ||||
| Loss before taxes | $ | (29,183 | ) | $ | (671 | ) | $ | (1,932 | ) | $ | (31,786 | ) | ||||
| Net loss | $ | (29,242 | ) | $ | (671 | ) | $ | (1,932 | ) | $ | (31,845 | ) | ||||
| Net loss per share available to common stockholders—basic and diluted | $ | (0.38 | ) | $ | (0.01 | ) | $ | (0.03 | ) | $ | (0.42 | ) | ||||
| Condensed Consolidated Statement of Operations (unaudited) | ||||||||||||||||
| (in thousands) | Six Months Ended | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Cost of goods sold | $ | 136,163 | $ | 6,531 | $ | — | $ | 142,694 | ||||||||
| Gross profit | $ | 7,526 | $ | (6,531 | ) | $ | — | $ | 995 | |||||||
| Selling, general and administrative expenses | $ | 85,368 | $ | — | $ | 4,242 | $ | 89,610 | ||||||||
| Total operating expenses | $ | 98,637 | $ | — | $ | 4,242 | $ | 102,879 | ||||||||
| Loss from operations | $ | (91,111 | ) | $ | (6,531 | ) | $ | (4,242 | ) | $ | (101,884 | ) | ||||
| Loss before taxes | $ | (82,088 | ) | $ | (6,531 | ) | $ | (4,242 | ) | $ | (92,861 | ) | ||||
| Net loss | $ | (82,158 | ) | $ | (6,531 | ) | $ | (4,242 | ) | $ | (92,931 | ) | ||||
| Net loss per share available to common stockholders—basic and diluted | $ | (1.08 | ) | $ | (0.08 | ) | $ | (0.06 | ) | $ | (1.22 | ) | ||||
| Condensed Consolidated Statement of Comprehensive Loss (unaudited) | ||||||||||||||||
| (in thousands) | Three Months Ended | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Net loss | $ | (29,242 | ) | $ | (671 | ) | $ | (1,932 | ) | $ | (31,845 | ) | ||||
| Comprehensive loss | $ | (31,710 | ) | $ | (671 | ) | $ | (1,932 | ) | $ | (34,313 | ) | ||||
| Condensed Consolidated Statement of Comprehensive Loss (unaudited) | ||||||||||||||||
| (in thousands) | Six Months Ended | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Net loss | $ | (82,158 | ) | $ | (6,531 | ) | $ | (4,242 | ) | $ | (92,931 | ) | ||||
| Comprehensive loss | $ | (85,666 | ) | $ | (6,531 | ) | $ | (4,242 | ) | $ | (96,439 | ) | ||||
| Condensed Consolidated Statement of Cash Flows (unaudited) | ||||||||||||||||
| (in thousands) | Six Months Ended | |||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | As Corrected | |||||||||||||
| Net loss | $ | (82,158 | ) | $ | (6,531 | ) | $ | (4,242 | ) | $ | (92,931 | ) | ||||
| Inventories | $ | 4,709 | $ | 6,531 | $ | — | $ | 11,240 | ||||||||
| Prepaid expense and other current assets | $ | (8,473 | ) | $ | — | $ | 5,623 | $ | (2,850 | ) | ||||||
| Net cash used in operating activities | $ | (59,355 | ) | $ | — | $ | 1,381 | $ | (57,974 | ) | ||||||
| Debt issuance costs | $ | (5,117 | ) | $ | — | $ | (1,381 | ) | $ | (6,498 | ) | |||||
| Net cash provided by financing activities | $ | 33,640 | $ | — | $ | (1,381 | ) | $ | 32,259 | |||||||
| Condensed Consolidated Balance Sheet (unaudited) | |||||||||||||||||||
| (in thousands) | As of | ||||||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | Impairment | As Corrected | |||||||||||||||
| Inventory | $ | 110,294 | $ | (8,534 | ) | $ | — | $ | — | $ | 101,760 | ||||||||
| Prepaid expenses and other current assets | $ | 31,048 | $ | — | $ | (17,593 | ) | $ | — | $ | 13,455 | ||||||||
| Total current assets | $ | 288,638 | $ | (8,534 | ) | $ | (17,593 | ) | $ | — | $ | 262,511 | |||||||
| Property, plant and equipment, net | $ | 254,387 | $ | — | $ | — | $ | 22,979 | $ | 277,366 | |||||||||
| Prepaid lease costs, non-current | $ | 35,704 | $ | — | $ | — | $ | 3,147 | $ | 38,851 | |||||||||
| Total assets | $ | 599,669 | $ | (8,534 | ) | $ | (17,593 | ) | $ | 26,126 | $ | 599,668 | |||||||
| Delayed draw term loan, net | $ | 77,734 | $ | — | $ | (3,451 | ) | $ | — | $ | 74,283 | ||||||||
| Delayed draw term loan warrants | $ | 14,825 | $ | — | $ | 544 | $ | — | $ | 15,369 | |||||||||
| Total long-term liabilities | $ | 1,320,092 | $ | — | $ | (2,907 | ) | $ | — | $ | 1,317,185 | ||||||||
| Accumulated deficit | $ | (1,434,377 | ) | $ | (8,534 | ) | $ | (14,686 | ) | $ | 26,126 | $ | (1,431,471 | ) | |||||
| Total stockholders’ deficit | $ | (784,065 | ) | $ | (8,534 | ) | $ | (14,686 | ) | $ | 26,126 | $ | (781,159 | ) | |||||
| Total liabilities and stockholders’ deficit | $ | 599,669 | $ | (8,534 | ) | $ | (17,593 | ) | $ | 26,126 | $ | 599,668 | |||||||
| Condensed Consolidated Statement of Operations (unaudited) | ||||||||||||||||||||
| (in thousands) | Three Months Ended | |||||||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | Impairment | As Corrected | ||||||||||||||||
| Cost of goods sold | $ | 62,988 | $ | 2,002 | $ | — | $ | — | $ | 64,990 | ||||||||||
| Gross profit | $ | 7,230 | $ | (2,002 | ) | $ | — | $ | — | $ | 5,228 | |||||||||
| Selling, general and administrative expenses | $ | 37,230 | $ | — | $ | 9,900 | $ | — | $ | 47,130 | ||||||||||
| Loss from impairment of long-lived assets | $ | 77,414 | $ | — | $ | — | $ | (26,126 | ) | $ | 51,288 | |||||||||
| Total operating expenses | $ | 119,561 | $ | — | $ | 9,900 | $ | (26,126 | ) | $ | 103,335 | |||||||||
| Loss from operations | $ | (112,331 | ) | $ | (2,002 | ) | $ | (9,900 | ) | $ | 26,126 | $ | (98,107 | ) | ||||||
| Remeasurement of warrant liability | $ | 5,318 | $ | — | $ | (544 | ) | $ | — | $ | 4,774 | |||||||||
| Total other income (expense), net | $ | 1,650 | $ | — | $ | (544 | ) | $ | — | $ | 1,106 | |||||||||
| Net loss | $ | (110,688 | ) | $ | (2,002 | ) | $ | (10,444 | ) | $ | 26,126 | $ | (97,008 | ) | ||||||
| Net loss per common share—basic and diluted | $ | (1.44 | ) | $ | (0.03 | ) | $ | (0.14 | ) | $ | 0.34 | $ | (1.27 | ) | ||||||
| Condensed Consolidated Statement of Operations (unaudited) | ||||||||||||||||||||
| (in thousands) | Nine Months Ended | |||||||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | Impairment | As Corrected | ||||||||||||||||
| Cost of goods sold | $ | 199,151 | $ | 8,534 | $ | — | $ | — | $ | 207,685 | ||||||||||
| Gross profit | $ | 14,756 | $ | (8,534 | ) | $ | — | $ | — | $ | 6,222 | |||||||||
| Selling, general and administrative expenses | $ | 122,598 | $ | — | $ | 14,142 | $ | — | $ | 136,740 | ||||||||||
| Loss from impairment of long-lived assets | $ | 77,414 | $ | — | $ | — | $ | (26,126 | ) | $ | 51,288 | |||||||||
| Total operating expenses | $ | 218,198 | $ | — | $ | 14,142 | $ | (26,126 | ) | $ | 206,214 | |||||||||
| Loss from operations | $ | (203,442 | ) | $ | (8,534 | ) | $ | (14,142 | ) | $ | 26,126 | $ | (199,992 | ) | ||||||
| Remeasurement of warrant liability | $ | 5,318 | $ | — | $ | (544 | ) | $ | — | $ | 4,774 | |||||||||
| Total other income (expense), net | $ | 10,673 | $ | — | $ | (544 | ) | $ | — | $ | 10,129 | |||||||||
| Loss before taxes | $ | (192,769 | ) | $ | (8,534 | ) | $ | (14,686 | ) | $ | 26,126 | $ | (189,863 | ) | ||||||
| Net loss | $ | (192,846 | ) | $ | (8,534 | ) | $ | (14,686 | ) | $ | 26,126 | $ | (189,940 | ) | ||||||
| Net loss per share available to common stockholders—basic and diluted | $ | (2.52 | ) | $ | (0.11 | ) | $ | (0.19 | ) | $ | 0.34 | $ | (2.48 | ) | ||||||
| Condensed Consolidated Statement of Comprehensive Loss (unaudited) | |||||||||||||||||||
| (in thousands) | Three Months Ended | ||||||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | Impairment | As Corrected | |||||||||||||||
| Net loss | $ | (110,688 | ) | $ | (2,002 | ) | $ | (10,444 | ) | $ | 26,126 | $ | (97,008 | ) | |||||
| Comprehensive loss | $ | (110,736 | ) | $ | (2,002 | ) | $ | (10,444 | ) | $ | 26,126 | $ | (97,056 | ) | |||||
| Condensed Consolidated Statement of Comprehensive Loss (unaudited) | |||||||||||||||||||
| (in thousands) | Nine Months Ended | ||||||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | Impairment | As Corrected | |||||||||||||||
| Net loss | $ | (192,846 | ) | $ | (8,534 | ) | $ | (14,686 | ) | $ | 26,126 | $ | (189,940 | ) | |||||
| Comprehensive loss | $ | (196,402 | ) | $ | (8,534 | ) | $ | (14,686 | ) | $ | 26,126 | $ | (193,496 | ) | |||||
| Condensed Consolidated Statement of Cash Flows (unaudited) | ||||||||||||||||||||
| (in thousands) | Nine Months Ended | |||||||||||||||||||
| As Previously Reported | Inventory Valuation | Debt Issuance Costs | Impairment | As Corrected | ||||||||||||||||
| Net loss | $ | (192,846 | ) | $ | (8,534 | ) | $ | (14,686 | ) | $ | 26,126 | $ | (189,940 | ) | ||||||
| Loss from impairment of long-lived assets | $ | 77,414 | $ | — | $ | — | $ | (26,126 | ) | $ | 51,288 | |||||||||
| Change in common stock warrant liabilities | $ | (5,318 | ) | $ | — | $ | 544 | $ | — | $ | (4,774 | ) | ||||||||
| Inventories | $ | 5,334 | $ | 8,534 | $ | — | $ | — | $ | 13,868 | ||||||||||
| Prepaid expenses and other current assets | $ | (1,322 | ) | $ | — | $ | 11,129 | $ | — | $ | 9,807 | |||||||||
| Net cash used in operating activities | $ | (98,138 | ) | $ | — | $ | (3,013 | ) | $ | — | $ | (101,151 | ) | |||||||
| Payments of debt issuance costs | $ | (10,314 | ) | $ | — | $ | 3,013 | $ | (7,301 | ) | ||||||||||
| Net cash provided by (used in) financing activities | $ | 87,821 | $ | — | $ | 3,013 | $ | 90,834 | ||||||||||||
Source: 